Would-be UFC competitor Aleksander
Doskalchuk has accepted a 14-month suspension from USADA for a
violation of the promotion’s anti-doping policy.
Doskalchuk tested positive for mesterolone metabolites in an
out-of-competition sample collected on June 6. Mesterolone is a
banned substance in the anabolic agents category. The flyweight
fighter will not be eligible to compete until August 2021.
Doskalchuk received a reduced sanction after providing evidence
that a doctor mistakenly provided him medication containing
mesterolone. The 30-year-old Ukrainian received an additional
reduction in his sanction thanks to his complete cooperation in the
investigation.
A former M-1 Global flyweight champion, Doskalchuk was expected to
compete at UFC Fight Night 172 on July 18 in Abu Dhabi but withdrew
from a proposed bout against Malcolm
Gordon. He owns a 10-1 professional record.
The full USADA statement regarding Doskalchuk is as follows:
USADA announced today that Oleksandr Doskalchuk, of Irpin,
Ukraine, has accepted a 14-month sanction for a violation of the
UFC® Anti-Doping Policy.
Doskalchuk, 30, tested positive for the mesterolone metabolites
1α-methyl-5α-androstan-3α-ol-17-one,
1α-methyl-5α-androstan-3α,17β-diol and
1α-methyl-5α-androstan-3,6,16-triol-17-one as the result of a
urine sample collected out-of-competition on June 6, 2020.
Mesterolone is a non-Specified Substance in the class of Anabolic
Agents and is prohibited at all times under the UFC Anti-Doping
Policy and UFC Prohibited List.
During an investigation into the circumstances of the case,
Doskalchuk provided evidence that a physician incorrectly
prescribed him a prohibited medication containing mesterolone
despite the fact that Doskalchuk sent him the UFC Wallet Card and
requested treatment permitted under the rules. As such, USADA
determined that Doskalchuk’s degree of fault was diminished and
that he should receive a reduced period of ineligibility.
Doskalchuk received an additional reduction to the otherwise
applicable period of ineligibility for his Full and Complete
Cooperation. Under the revised UFC ADP announced on November 25,
2019, a Full and Complete Cooperation reduction may be granted in
the event that an athlete demonstrates that they did not intend to
enhance their performance and provided full, prompt, and truthful
responses and information to all reasonable inquiries and requests
for information.
Doskalchuk’s 14-month period of ineligibility began on June 6,
2020, the date his positive sample was collected.